Guangdong VTR Bio-Tech Co., Ltd.

Shenzhen Stock Exchange 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd. Receivables for the year ending December 31, 2023: USD 32.66 M

Guangdong VTR Bio-Tech Co., Ltd. Receivables is USD 32.66 M for the year ending December 31, 2023, a -9.40% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.
  • Guangdong VTR Bio-Tech Co., Ltd. Receivables for the year ending December 31, 2022 was USD 36.05 M, a -59.48% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Receivables for the year ending December 31, 2021 was USD 88.97 M, a -3.94% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Receivables for the year ending December 31, 2020 was USD 92.62 M, a 8.75% change year over year.
  • Guangdong VTR Bio-Tech Co., Ltd. Receivables for the year ending December 31, 2019 was USD 85.17 M, a 17.78% change year over year.
Key data
Date Receivables Inventory Goodwill Total Assets
Market news
SV Wall Street
Shenzhen Stock Exchange: 300381.SZ

Guangdong VTR Bio-Tech Co., Ltd.

CEO Mr. Derong Zhou
IPO Date Jan. 28, 2014
Location China
Headquarters No. 8 Pingbei Road 1
Employees 1,119
Sector Healthcare
Industries
Biotechnology Agriculture Biofuel Fertilizers Personal Care Pet Food Pharmaceuticals Plastics
Description

Guangdong VTR Bio-Tech Co., Ltd., focuses on research, development, and industrial application of bio-medicine, bio-agriculture, and animal husbandry. The company provides feed enzymes, functional feed additives, and industrial enzyme products. The company sells its products in approximately 60 countries and regions. Guangdong VTR Bio-Tech Co., Ltd. was founded in 1991 and is headquartered in Zhuhai, China.

StockViz Staff

February 3, 2025

Any question? Send us an email